UNSPSC 51451702: Kainic acid

This classification denotes an antihelminthic agent with the molecular formula C10H15NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SIV03811UC, chemically known as 3-pyrrolidineacetic acid, 2-carboxy-4- (1-methylethenyl)- but generally known as kainic acid, which bears US NIH Compound Identifier 3816. European Medicines Agency schedules Kainic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08360MIG.

UNSPSC 51451702 Kainic acid is a Commodity code that in recent state and local procurement shows little activity aligned with its nominal scope. The recent opportunities tagged under this code do not include kainic acid itself but instead reflect broader pharmaceutical and medical supply procurement — naloxone (an opioid antagonist), generic multi-source pharmaceuticals and OTC products, and emergency medical supplies for fire departments. The code's abstract name does not match what state and local buyers are actually sourcing under it in practice, signaling either a tagging misalignment in the source data or a mismatch between the UNSPSC taxonomy and current procurement practice for this category.

The issuing bodies across recent opportunities span state health departments (Texas Health and Human Services Commission), multicounty cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), county health authorities (Seminole County, Florida), and municipalities (City of Tampa Fire Department). The geographic spread includes Texas, Minnesota, Florida, and Oregon. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a due date of July 26, 2023; the City of Tampa's sealed-bid procurement (26P00145) for 169 line items of emergency medical supplies for the Fire Department, estimated at $700,000.00 and designated as sheltered for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic pharmaceuticals and OTC products with a response deadline of March 26, 2026. Given the evident mismatch between the code name and the actual work being sourced, vendors should verify code assignment with issuing bodies before pursuing opportunities in this category.